Indefinite Delivery Contract HHSF223201510025I

This indefinite delivery contract (IDC) was awarded by a U.S. federal government agency to IIT Research Institute (IITRI), a non-profit contract research organization. The IDC is a multiple-award vehicle with a $0 ceiling value and an ultimate completion date of September 30, 2007. Under this IDC, IITRI provides a range of preclinical research services to support federal agencies such as the National Institutes of Health (NIH), including the National Cancer Institute (NCI), National Institute of...

This Indefinite Delivery Contract (IDC) is a single-award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development organization. The contract, valued at a ceiling of $342,897, is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES over a 5-year period of performance from September 27, 2021 to April 25, 2025. The contract was not set aside for any specific business size or socioeconomic...

The Indefinite Delivery Contract (IDC) awarded to Scientific Consulting Group Inc., a woman-owned small business, under the Public Information and Communications Services II (PICS II) contract vehicle aims to provide a range of professional services to federal agencies. The key products and services being delivered include communications, outreach, technical and scientific support, conference planning, website design, analytical services, and technical writing. The contract has a ceiling value...

This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Research Triangle Institute (RTI International), a non-profit research organization, for ECONOMIC STUDIES OF FDA REGULATIONS. The single-award IDC has a ceiling value of $5,000,000.00 and a period of performance through September 19, 2029. Under this contract, RTI International will provide a range of technical and advisory services to support the FDA's regulatory and...

This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The contract has a ceiling value of $48,882,666.00 and a period of performance through August 5, 2030. The purpose of this IDC is to obtain pharmacology studies, animal model development, and related services to support NCATS' Division of Preclinical Innovation drug...

This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $48.6 million multiple-award IDC has a 6-year ordering period from June 2024 to June 2030. The contract aims to procure safety evaluation and toxicology studies and related services to support drug development efforts at NCATS....

This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit biomedical research services company, to support the Simian Vaccine Evaluation Units (SVEU) program. The $66,355,351.00 IDC, which has an ultimate completion date of March 31, 2027, provides a vehicle for NIAID to issue delivery orders to Bioqual for conducting specialized research studies, providing laboratory analysis, and...

The key products and services being delivered under this Indefinite Delivery Contract (IDC) awarded by the National Aeronautics and Space Administration (NASA) Johnson Space Center to the Potomac Institute for Policy Studies, a non-profit research organization, include technology forecast services, strategic planning, policy analysis, and specialized research studies to support NASA's medical research, pharmaceutical, space nutrition, omics, and biomonitoring programs. The contract, which has...

This Indefinite Delivery Contract is a parent IDIQ vehicle awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Southern Research Institute, a non-profit research organization. The Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ has a total potential value of $174,470,000 and a period of performance through September 12, 2026. Under this IDIQ, Southern Research has been awarded multiple task orders to provide drug discovery,...

The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a multiple award indefinite delivery/indefinite quantity (IDIQ) contract by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the U.S. Department of Health and Human Services. The contract, with a total ceiling value of $48,000,000 over 7 years, is to serve as a clinical research site for the NIAAA Medications Development Clinical Investigations Network,...